Wealthfront’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $1.81M | Buy |
29,093
+7,648
| +36% | +$475K | 0.02% | 139 |
|
|
2018
Q2 | $1.19M | Sell |
21,445
-25,544
| -54% | -$1.41M | 0.01% | 215 |
|
|
2018
Q1 | $2.97M | Buy |
46,989
+7,291
| +18% | +$461K | 0.03% | 93 |
|
|
2017
Q4 | $2.43M | Buy |
39,698
+1,814
| +5% | +$111K | 0.03% | 97 |
|
|
2017
Q3 | $2.42M | Buy |
37,884
+8,709
| +30% | +$555K | 0.03% | 95 |
|
|
2017
Q2 | $1.63M | Buy |
29,175
+4,599
| +19% | +$256K | 0.02% | 112 |
|
|
2017
Q1 | $1.34M | Sell |
24,576
-10,936
| -31% | -$595K | 0.02% | 116 |
|
|
2016
Q4 | $2.08M | Buy |
35,512
+21,617
| +156% | +$1.26M | 0.05% | 73 |
|
|
2016
Q3 | $749K | Sell |
13,895
-27,665
| -67% | -$1.49M | 0.02% | 138 |
|
|
2016
Q2 | $3.06M | Buy |
41,560
+11,160
| +37% | +$821K | 0.08% | 46 |
|
|
2016
Q1 | $1.94M | Sell |
30,400
-9,646
| -24% | -$616K | 0.06% | 61 |
|
|
2015
Q4 | $2.76M | Buy |
40,046
+12,645
| +46% | +$870K | 0.1% | 40 |
|
|
2015
Q3 | $1.62M | Buy |
27,401
+11,331
| +71% | +$671K | 0.06% | 60 |
|
|
2015
Q2 | $1.07M | Buy |
16,070
+4,684
| +41% | +$312K | 0.04% | 54 |
|
|
2015
Q1 | $734K | Buy |
11,386
+1,451
| +15% | +$93.5K | 0.04% | 57 |
|
|
2014
Q4 | $586K | Buy |
9,935
+2,353
| +31% | +$139K | 0.03% | 62 |
|
|
2014
Q3 | $388K | Buy |
7,582
+5,244
| +224% | +$268K | 0.03% | 75 |
|
|
2014
Q2 | $113K | Sell |
2,338
-783
| -25% | -$37.8K | 0.01% | 197 |
|
|
2014
Q1 | $162K | Buy |
+3,121
| New | +$162K | 0.02% | 72 |
|